Literature DB >> 22382160

Neurointerventional procedural volume per hospital in United States: implications for comprehensive stroke center designation.

Mikayel Grigoryan1, Saqib A Chaudhry, Ameer E Hassan, Fareed K Suri, Adnan I Qureshi.   

Abstract

BACKGROUND AND
PURPOSE: Availability of neurointerventional procedures is recommended as a necessary component of a comprehensive stroke center by various regulatory guidelines that also emphasize adequate procedural volumes. We studied the volumes of neurointerventional procedures performed in various hospitals across the United States with subsequent comparisons with rates of minimum procedural volumes recommended by various professional bodies or used in clinical trials to ensure adequate operator experience.
METHODS: We reviewed the Nationwide Inpatient Sample database in the United States for the years 2005 to 2008. Using International Classification of Disease-Clinical Modification, 9th revision, and Medicare severity diagnosis-related group codes, we identified among hospitals that admit stroke patients those that met the minimum criteria for overall and individual procedural volumes specified in various guidelines. We then compared the characteristics between the high-volume hospitals that performed at least 100 cervicocerebral angiograms and met ≥1 other procedural criterion (n=79) and low-volume hospitals (n=958).
RESULTS: Proportions of hospitals that met individual procedural volume criteria over the 4-year period according to procedure were: cervicocerebral angiography (7.0%-7.8%); endovascular acute ischemic stroke treatments (0.4%-2.6%); carotid angioplasty/stent placement (3.0%-5.3%); intracranial angioplasty/stent placement (0.3%-1.3%); and aneurysm embolization (1.3%-2.6%). There were significant trends for increasing numbers of all the endovascular procedures except intracranial angioplasty/stent placement over the course of 4 years. The high-volume hospitals were more likely to be urban teaching hospitals (70.9% versus 13.1%; P<0.001), had larger bed size (79.7% versus 26.9%; P<0.001), and had significantly higher rates of hemorrhagic stroke admissions and lower rates of transient ischemic attack admissions. Urban teaching location/status (OR, 8.92; CI, 4.3-18.2; P<0.001) and large bed size (OR, 4.40; CI, 2.0-9.5; P<0.001) remained as independent predictors of a high-volume hospital when adjusted for age, gender, risk factors, and stroke subtype.
CONCLUSIONS: There are very few hospitals in the United States that meet all the neurointerventional procedural volume criteria for all endovascular procedures recommended to ensure adequate operator experience. Our results support the creation of specialized regional centers for ensuring adequate procedural volume within treating hospitals.

Entities:  

Mesh:

Year:  2012        PMID: 22382160     DOI: 10.1161/STROKEAHA.111.636076

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

1.  Trends in hospital procedure volumes for intra-arterial treatment of acute ischemic stroke: results from the paul coverdell national acute stroke program.

Authors:  Ganesh Asaithambi; Xin Tong; Kamakshi Lakshminarayan; Sallyann M Coleman King; Mary G George
Journal:  J Neurointerv Surg       Date:  2020-03-13       Impact factor: 5.836

Review 2.  Endovascular Treatment versus Best Medical Treatment in Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.

Authors:  A I Qureshi; M F Ishfaq; H A Rahman; A P Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-21       Impact factor: 3.825

3.  Deep learning based detection of intracranial aneurysms on digital subtraction angiography: A feasibility study.

Authors:  Nicolin Hainc; Manoj Mannil; Vaia Anagnostakou; Hatem Alkadhi; Christian Blüthgen; Lorenz Wacht; Andrea Bink; Shakir Husain; Zsolt Kulcsár; Sebastian Winklhofer
Journal:  Neuroradiol J       Date:  2020-07-07

4.  Reduced Patient Radiation Exposure during Neurodiagnostic and Interventional X-Ray Angiography with a New Imaging Platform.

Authors:  K van der Marel; S Vedantham; I M J van der Bom; M Howk; T Narain; K Ty; A Karellas; M J Gounis; A S Puri; A K Wakhloo
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-19       Impact factor: 3.825

5.  Mechanical thrombectomy in acute stroke: utilization variances and impact of procedural volume on inpatient mortality.

Authors:  Peter Adamczyk; Frank Attenello; Ge Wen; Shuhan He; Jonathan Russin; Nerses Sanossian; Arun Paul Amar; William J Mack
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-25       Impact factor: 2.136

6.  Endovascular treatment for acute ischemic stroke.

Authors:  Alfonso Ciccone; Luca Valvassori; Michele Nichelatti; Annalisa Sgoifo; Michela Ponzio; Roberto Sterzi; Edoardo Boccardi
Journal:  N Engl J Med       Date:  2013-02-06       Impact factor: 91.245

7.  Racial and socioeconomic disparities in access to mechanical revascularization procedures for acute ischemic stroke.

Authors:  Frank J Attenello; Peter Adamczyk; Ge Wen; Shuhan He; Katie Zhang; Jonathan J Russin; Nerses Sanossian; Arun P Amar; William J Mack
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-05-13       Impact factor: 2.136

8.  Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: A 7M Management Approach to Developing a Stroke Interventional Laboratory in the Era of Stroke Thrombectomy for Large Vessel Occlusions.

Authors:  Tanzila Shams; Osama Zaidat; Dileep Yavagal; Andrew Xavier; Tudor Jovin; Vallabh Janardhan
Journal:  Interv Neurol       Date:  2016-02-26

Review 9.  Review of stroke center effectiveness and other get with the guidelines data.

Authors:  Gisele Sampaio Silva; Lee H Schwamm
Journal:  Curr Atheroscler Rep       Date:  2013-09       Impact factor: 5.113

Review 10.  Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice.

Authors:  Murugan Palaniswami; Bernard Yan
Journal:  Interv Neurol       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.